The Health Minster of Panama, Luis Sucre, said on 7 February 2021 that Panama is seeking to acquire over eight million COVID-19 vaccine doses to inoculate about 80% of the country's residents, Reuters news agency reported on Monday.
According to Sucre, Panama has requested about one million doses from the COVID-19 vaccine portfolio under the COVAX facility coordinated by the World Health Organisation to support lower-income countries.
It will acquire a further three million doses from US pharmaceutical firm Pfizer Inc and the same amount from Russia, which has developed the Sputnik V COVID-19 vaccine.
Sucre added that Panama also aims to acquire 1.1 million doses manufactured by AstraZeneca PLC and 300,000 shots produced by Johnson & Johnson.
Reportedly, Panama has a population of about 4.2 million people but most COVID-19 vaccines require two shots spaced several weeks apart.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development